title: [Determination of critical kanamycin concentration for Mycobacterium tuberculosis in the MGIT Bactec 960 system].
abstract: The critical concentration of canamycin for the MGIT Bactec 960 system, which has been determined on a panel of the tho--roughly characterized genetically heterogeneous clinical Mycobacterium tuberculosis isolated in the Central Region of Russia, is equal to 1.25 microg/ml.
authors.forename: V N
authors.initials: VN
authors.lastname: Stepanshina
authors.forename: S A
authors.initials: SA
authors.lastname: Popov
authors.forename: N A
authors.initials: NA
authors.lastname: Aparina
authors.forename: R I
authors.initials: RI
authors.lastname: Mironova
authors.forename: T N
authors.initials: TN
authors.lastname: Mukhina
authors.forename: A V
authors.initials: AV
authors.lastname: Nizova
authors.forename: N V
authors.initials: NV
authors.lastname: Maĭskaia
authors.forename: O G
authors.initials: OG
authors.lastname: Nikolaeva
authors.forename: A G
authors.initials: AG
authors.lastname: Bogun
authors.forename: S A
authors.initials: SA
authors.lastname: Blagodatskikh
authors.forename: I G
authors.initials: IG
authors.lastname: Shemiakin
authors.forename: P
authors.initials: P
authors.lastname: Cegelski
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004269:DNA, Bacterial / Q000032:analysis*; D004305:Dose-Response Relationship, Drug; D004867:Equipment Design; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage*; D008826:Microbial Sensitivity Tests / Q000295:instrumentation*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D007612:Kanamycin